EE200100020A - NAB1 ja NAB2 farmatseutiline kasutamine - Google Patents
NAB1 ja NAB2 farmatseutiline kasutamineInfo
- Publication number
- EE200100020A EE200100020A EEP200100020A EEP200100020A EE200100020A EE 200100020 A EE200100020 A EE 200100020A EE P200100020 A EEP200100020 A EE P200100020A EE P200100020 A EEP200100020 A EE P200100020A EE 200100020 A EE200100020 A EE 200100020A
- Authority
- EE
- Estonia
- Prior art keywords
- nab1
- nab2
- pharmaceutical use
- pharmaceutical
- Prior art date
Links
- 101000583053 Homo sapiens NGFI-A-binding protein 1 Proteins 0.000 title 1
- 101000583057 Homo sapiens NGFI-A-binding protein 2 Proteins 0.000 title 1
- CZSLEMCYYGEGKP-UHFFFAOYSA-N N-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)benzimidazole-5-carboxamide Chemical compound CC1=CC=C(C)C(N2C3=CC=C(C=C3N=C2)C(=O)NCC=2C(=CC=CC=2)Cl)=C1 CZSLEMCYYGEGKP-UHFFFAOYSA-N 0.000 title 1
- 102100030407 NGFI-A-binding protein 1 Human genes 0.000 title 1
- 102100030391 NGFI-A-binding protein 2 Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814989.1A GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
| GBGB9819826.0A GB9819826D0 (en) | 1998-09-12 | 1998-09-12 | Gene therapy method |
| PCT/GB1999/002199 WO2000003014A1 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100020A true EE200100020A (et) | 2002-06-17 |
Family
ID=26314007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100020A EE200100020A (et) | 1998-07-11 | 1999-07-09 | NAB1 ja NAB2 farmatseutiline kasutamine |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1097200A1 (is) |
| JP (1) | JP2002520020A (is) |
| KR (1) | KR20010071832A (is) |
| CN (1) | CN1317045A (is) |
| AP (1) | AP2001002038A0 (is) |
| AU (1) | AU763713B2 (is) |
| BR (1) | BR9912018A (is) |
| CA (1) | CA2336805A1 (is) |
| EA (1) | EA200100028A1 (is) |
| EE (1) | EE200100020A (is) |
| HR (1) | HRP20010025A2 (is) |
| HU (1) | HUP0102835A3 (is) |
| ID (1) | ID27742A (is) |
| IL (1) | IL140533A0 (is) |
| IS (1) | IS5788A (is) |
| NO (1) | NO20010166L (is) |
| NZ (1) | NZ509174A (is) |
| PL (1) | PL345507A1 (is) |
| SK (1) | SK382001A3 (is) |
| TR (1) | TR200100622T2 (is) |
| WO (1) | WO2000003014A1 (is) |
| YU (1) | YU1901A (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9928430D0 (en) * | 1999-12-01 | 2000-01-26 | Glaxo Group Ltd | Screening |
| AU2001291019A1 (en) | 2000-09-15 | 2002-03-26 | Genvec, Inc. | Method of modulating neovascularization |
| WO2004083435A1 (en) * | 2003-03-17 | 2004-09-30 | Julius-Maximilians-Uni Versität Würzburg | Nab proteins and their use in diagnostic and therapeutic applications in heart disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036006A (en) * | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5697901A (en) * | 1989-12-14 | 1997-12-16 | Elof Eriksson | Gene delivery by microneedle injection |
-
1999
- 1999-07-09 HR HR20010025A patent/HRP20010025A2/hr not_active Application Discontinuation
- 1999-07-09 WO PCT/GB1999/002199 patent/WO2000003014A1/en not_active Ceased
- 1999-07-09 TR TR2001/00622T patent/TR200100622T2/xx unknown
- 1999-07-09 EE EEP200100020A patent/EE200100020A/xx unknown
- 1999-07-09 CA CA002336805A patent/CA2336805A1/en not_active Abandoned
- 1999-07-09 YU YU1901A patent/YU1901A/sh unknown
- 1999-07-09 JP JP2000559235A patent/JP2002520020A/ja active Pending
- 1999-07-09 IL IL14053399A patent/IL140533A0/xx unknown
- 1999-07-09 BR BR9912018-6A patent/BR9912018A/pt not_active IP Right Cessation
- 1999-07-09 CN CN99810616A patent/CN1317045A/zh active Pending
- 1999-07-09 EA EA200100028A patent/EA200100028A1/ru unknown
- 1999-07-09 AP APAP/P/2001/002038A patent/AP2001002038A0/en unknown
- 1999-07-09 NZ NZ509174A patent/NZ509174A/en unknown
- 1999-07-09 AU AU47914/99A patent/AU763713B2/en not_active Ceased
- 1999-07-09 KR KR1020017000413A patent/KR20010071832A/ko not_active Withdrawn
- 1999-07-09 SK SK38-2001A patent/SK382001A3/sk unknown
- 1999-07-09 EP EP99931378A patent/EP1097200A1/en not_active Withdrawn
- 1999-07-09 PL PL99345507A patent/PL345507A1/xx not_active Application Discontinuation
- 1999-07-09 ID IDW20010345A patent/ID27742A/id unknown
- 1999-07-09 HU HU0102835A patent/HUP0102835A3/hu unknown
-
2000
- 2000-12-22 IS IS5788A patent/IS5788A/is unknown
-
2001
- 2001-01-10 NO NO20010166A patent/NO20010166L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AP2001002038A0 (en) | 2001-03-31 |
| TR200100622T2 (tr) | 2001-10-22 |
| CA2336805A1 (en) | 2000-01-20 |
| BR9912018A (pt) | 2006-01-31 |
| IS5788A (is) | 2000-12-22 |
| AU763713B2 (en) | 2003-07-31 |
| EP1097200A1 (en) | 2001-05-09 |
| AU4791499A (en) | 2000-02-01 |
| NO20010166L (no) | 2001-03-06 |
| YU1901A (sh) | 2005-06-10 |
| HRP20010025A2 (en) | 2001-12-31 |
| NO20010166D0 (no) | 2001-01-10 |
| IL140533A0 (en) | 2002-02-10 |
| HUP0102835A2 (hu) | 2001-11-28 |
| SK382001A3 (en) | 2001-09-11 |
| NZ509174A (en) | 2003-08-29 |
| HUP0102835A3 (en) | 2003-09-29 |
| CN1317045A (zh) | 2001-10-10 |
| PL345507A1 (en) | 2001-12-17 |
| WO2000003014A1 (en) | 2000-01-20 |
| ID27742A (id) | 2001-04-26 |
| KR20010071832A (ko) | 2001-07-31 |
| EA200100028A1 (ru) | 2001-08-27 |
| JP2002520020A (ja) | 2002-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000232A (et) | Farmatseutiline kompositsioon ja selle kasutamine | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
| PT1066027E (pt) | Composicao farmaceutica de topiramato | |
| PT1119557E (pt) | Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos | |
| DE69925262D1 (de) | Pharmazeutika zur bildgebung der angiogenischen krankheiten | |
| EE200100258A (et) | Antraniilhappe amiidid ja nende kasutamine ravimitena | |
| FI972292A0 (fi) | Administrering av diabetes | |
| FI953479A7 (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
| PT934057E (pt) | Formulacoes medicinais de aerossois com formoterol | |
| PT1006110E (pt) | Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos | |
| LV12624B (lv) | Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana | |
| FI971750A0 (fi) | Koostumuksia multippeliskleroosia varten ja sen hoito | |
| NO965564D0 (no) | Medisinsk anvendelse av bromelain | |
| DE69900823D1 (de) | Injizierbare arzneizubereitung bestehend aus paracetamol | |
| FI964482A7 (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
| ATA191697A (de) | Arzneimittel zur förderung der wundheilung | |
| EE04870B1 (et) | Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid | |
| EE200100051A (et) | Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon | |
| PT1194038E (pt) | Composicao de quebra do repouso e sua utilizacao | |
| EP0914611A4 (en) | TRANSACTIVATION OF LEPTIN | |
| EE200100020A (et) | NAB1 ja NAB2 farmatseutiline kasutamine | |
| EE200100084A (xx) | NOS inhibiitorite uued farmatseutilised kasutusv�imalused | |
| FI963263A0 (fi) | Bromelaiinin lääkinnällinen käyttö |